|
|
|
|
|
|
by Scoundreller
2495 days ago
|
|
|
> And J&J is by no means a major opioid manufacturer The had the non-hospital fentanyl market cornered for a while. Their patches were only for chronic use by patients already tolerant to opioids. Even if they had less than 1% of the market, they would have had a much larger proportion of the high-dose market, where mortality risk ramps up. |
|
|